✓ No loaded language, vague sourcing, or framing detected.
A recent study indicates that an mRNA vaccine, when combined with the immunotherapy drug Keytruda, is effective in preventing melanoma recurrence. The study involved participants including an 80-year-old woman who took part in the trial.
Our neutral summary
A recent study indicates that an mRNA vaccine, when combined with the immunotherapy drug Keytruda, is effective in preventing melanoma recurrence. The study involved participants including an 80-year-old woman who took part in the trial.
The reporting belongs to NPR — Top Stories; we don't reproduce it.
No note attached
on this article.
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma
Study Shows mRNA Vaccine Effective in Preventing Melanoma Recurrence